• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Clindamycin HCl
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Dalacin C 150 mg/ml
    Pfizer
    RX
    partial basket chart
    Dalacin C 150 mg/ml

    Lincosamide. Clindamycin HCl 150 mg/ml.
    VIALS: 1×600 mg/4 ml. Intra-abdom., female pelvic or other complic./serious infects: 2,400-2,700 mg/day in 2/3 or 4 equal doses.
    Less complic. infects: 1,200-1,800 
    mg/day in 3-4 equal doses. Doses up to 4,800 mg/day have been used successfully. All I.M./I.V. Single I.M. doses above 600 mg not recommend.
    Child over 1 mth: 20-40 mg/kg/day in 3-4 equal doses.
    Neonotes (< 1 mth): 
    15-20 mg/kg/day in 3-4 equal doses.
    Tmt. of infec. caused by suscept. anaerobic bacteria.
    C/I: History of hypersens. to preparations contain. clindamycin or lincomycin.
    Dalacin C 150mg/ml sol. for inj. must not be given to premature babies or neonates because of the benzyl alcohol content.

    Dalacin® C Capsules 150 mg, 300 mg
    Pfizer
    RX
    partial basket chart
    Dalacin® C Capsules 150 mg, 300 mg

    Lincosamide. Clindamycin HCl 150 mg, 300 mg.
    CAPS: 16, 100×150 mg , 16×300 mg. 150 mg every 6 hrs. More serious infects: 300 mg every 6 hrs.
    Severe 
    infects: 450 mg every 6 hrs.
    Child: 
    Severe infects: 8-16 mg/kg/day in 3-4 div. doses. More severe infects: 16-20 mg/kg/day in 3-4 div. doses.
    Tmt. of infec. caused by suscept. anaerobic bacteria.
    C/I: History of hypersens. to preparations contain. clindamycin or lincomycin.
    Dalacin C 150mg/ml sol. for inj. must not be given to premature babies or neonates because of the benzyl alcohol content.

     

    CLOSE